|
Every hospital wants the best start for a newborn in their care. But exposure to certain drugs and medications during pregnancy can affect the newborn’s health. Selective serotonin reuptake inhibitors (SSRIs) are a class of drugs that can be used to treat depression, anxiety, or other psychological disorders, but these medications can have significant effects on newborns:
- 30% of SSRI-exposed infants experience neonatal adaptation syndrome.(1)
- Symptoms may include jitteriness, poor feeding, and respiratory distress.(1)
- SSRI exposure is associated with earlier onset of emotional disorders in childhood.(2)
Our state-of-the-art SSRI testing in umbilical cord tissue identifies in-utero exposure to help your hospital provide appropriate attention in the crucial first days of life.
Taking action is simple:
- Call us or schedule a meeting
- Request SSRI testing for your organization
- Receive results in 1-3 business days
The following analytes will be included in the panel or add-on option:
|
